1. Bailey DL, Townsend DW, Valk PE, Maisey MN, editors. Positron emission tomography: basic sciences. London: Springer-Verlag; 2005.
2. Pimlott SL, Sutherland A. Molecular tracers for the PET and SPECT imaging of disease. Chem Soc Rev. 2011;40(1):149–62.
3. Schirrmeister H, Glatting G, Hetzel J, Nussle K, Arslandemir C, Buck AK, Dziuk K, Gabelmann A, Reske SN, Hetzel M. Prospective evaluation of the clinical value of planar bone scans, SPECT, and 18f-labeled NaF PET in newly diagnosed lung cancer. J Nucl Med. 2001;42(12):1800–4.
4. Fass L. Imaging and cancer: a review. Mol Oncol. 2008;2(2):115–52.
5. Schirrmeister H, Kuhn T, Guhlmann A, Santjohanser C, Horster T, Nussle K, Koretz K, Glatting G, Rieber A, Kreienberg R, Buck AC, Reske SN. Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures. Eur J Nucl Med. 2001;28(3):351–8.